Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
20141
TMD-5 intrinsic Trp fluorescence assay.
Published 2012“…(b), Pentamidine decreases Trp emission fluorescence intensity of TMD-5 in 150 µM C14 betaine and 50 mM HEPES (pH = 7.4) buffer in a dose-dependent manner. …”
-
20142
Inhibition correlates with cellular PmV levels.
Published 2015“…DC6 clone expresses PmV-GFP chimera under regulation of the native promoter [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]; G6 clone, the PmV-GFP-DD chimera under regulation of the native promoter (this paper) and #3 clone (episomally expressing PmV-GFP chimera under <i>Hsp86-5'</i>, a strong and constitutive promoter) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]. …”
-
20143
MCPyV circALTO can be translated.
Published 2021“…<p>(A) CircALTOs do not inhibit MCPyV miRNA function in vitro. 293 cells were transfected with <i>Renilla</i> luciferase reporter with a 300 nucleotide region complementary to the MCPyV miRNA and the indicated plasmids including a MCPyV-miRNA-M1 expression plasmid (derived from isolate MCV350), pCDNA3.1 control vector, pCDNA circALTO1 (pcircALTO1) or pCDNA circALTO2 (pcircALTO2) expression plasmid. …”
-
20144
-
20145
V2G controls parameters [36].
Published 2023“…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”
-
20146
Dynacortin facilitates polarization of chemotaxing cells-5
Published 2011“…A total of 2.5 M actin was present in each sample. …”
-
20147
Plants components in five-flower remedy [24].
Published 2025“…This study aimed to explore the potential antimalarial and neuroprotective properties of the five-flower remedy (FFR), a traditional herbal formulation, in experimental cerebral malaria (ECM). …”
-
20148
Five multi-target tracking evaluation indexes.
Published 2025“…<div><p>A real-time stable multi-target tracking method based on the enhanced You Only Look Once-v8 (YOLOv8) and the optimized Simple Online and Realtime Tracking with a Deep association metric (DeepSORT) for real-time stable multi-target tracking (S-YOFEO) is proposed to address the issue of target ID transformation and loss caused by the increase of practical background complexity. …”
-
20149
-
20150
Ctcf and Smarca5 interact in AML cells.
Published 2014“…D Smarca5 at ICR upon Ctcf knockdown. Occupancy of Smarca5 (lysates from 1A) by ChIP. …”
-
20151
Five onset times and results for musculoskeletal simulation.
Published 2022“…<p>(A) The five different onset times were at 12%, 18%, 24%, 30%, and 36% of the gait cycle. …”
-
20152
Image_5_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.JPEG
Published 2019“…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
-
20153
Table_5_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX
Published 2019“…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
-
20154
Patients’ responses to EQ5-D items.
Published 2024“…</p><p>Result</p><p>This study included 68.8% females, with a median age of 58 (50–64) years. The median EQ5-D index score was 0.66 (0.41–0.78). …”
-
20155
Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs
Published 2020“…Endogenous ligands, such as hormones and neurotransmitters, bind to the orthosteric site, while synthetic ligands may bind to orthosteric or allosteric sites, which has become a focal point in drug discovery. Usually, such allosteric modulators bind to a protein noncompetitively with its endogenous ligand or substrate. …”
-
20156
Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs
Published 2020“…Endogenous ligands, such as hormones and neurotransmitters, bind to the orthosteric site, while synthetic ligands may bind to orthosteric or allosteric sites, which has become a focal point in drug discovery. Usually, such allosteric modulators bind to a protein noncompetitively with its endogenous ligand or substrate. …”
-
20157
Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs
Published 2020“…Endogenous ligands, such as hormones and neurotransmitters, bind to the orthosteric site, while synthetic ligands may bind to orthosteric or allosteric sites, which has become a focal point in drug discovery. Usually, such allosteric modulators bind to a protein noncompetitively with its endogenous ligand or substrate. …”
-
20158
Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs
Published 2020“…Endogenous ligands, such as hormones and neurotransmitters, bind to the orthosteric site, while synthetic ligands may bind to orthosteric or allosteric sites, which has become a focal point in drug discovery. Usually, such allosteric modulators bind to a protein noncompetitively with its endogenous ligand or substrate. …”
-
20159
-
20160